Contents

Current Drug Discovery Technologies, Volume 13 - Number 2

Meet Our Editor

, 13(2): 58 - 59

Vladimir Torchilin


DOI: 10.2174/157016381302160623143936




Drug Discovery and Development of Type 2 Diabetes Mellitus: Modern-Integrative Medicinal Approach

, 13(2): 60 - 67

Debosree Ghosh and Pratap Parida


DOI: 10.2174/1570163813666160414105327




Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma

, 13(2): 68 - 76

Akash Verma, Akhil Chopra, Yeo W. Lee, Lavina D. Bharwani, Atasha B. Asmat, Dokeu B.A Aneez, Fazuludeen A. Akbar, Albert Y.H. Lim, Sanjay H. Chotirmall and John Abisheganaden


DOI: 10.2174/1570163813666160524142846




Development and Assessment of a Gas Chromatographic Based Method for the Quantification of Thymol from Cream Based Formulation

, 13(2): 77 - 83

Soliman Mohammadi Samani, Mahmoodreza Moein, Peyman Petramfar and Mohammad M. Zarshenas


DOI: 10.2174/1570163813666160519111145




Insight into the Structural Requirements of Theophylline-Based Aldehyde Dehydrogenase lAl (ALDHlAl) Inhibitors Through Multi-QSAR Modeling and Molecular Docking Approaches

, 13(2): 84 - 100

Sk. Abdul Amin, Nilanjan Adhikari, Shovanlal Gayen and Tarun Jha


DOI: 10.2174/1570163813666160429115628




Quantitative Structure-Cytotoxic Activity Relationship 1-(Benzoyloxy)urea and Its Derivative

, 13(2): 101 - 108

Suko Hardjono, Siswandono Siswodihardjo, Purwanto Pramono and Win Darmanto


DOI: 10.2174/1570163813666160525112327




Imidazolium Ionic Liquids as Potential Anti-Candida Inhibitors: QSAR Modeling and Experimental Studies

, 13(2): 109 - 119

Diana Hodyna, Vasyl Kovalishyn, Sergiy Rogalsky, Volodymyr Blagodatnyi and Larisa Metelytsia


DOI: 10.2174/1570163813666160510122201




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science